British journal of Cancer |
Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma |
Jan. 19 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma |
sep. 15 |
1 ♥ |
Carcinome hépatocellulaire (CHC), Foie |
British journal of Cancer |
Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach |
juin. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer |
nov. 17 |
3 ♥ |
Cancers autres |
British journal of Cancer |
Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer |
sep. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
British journal of Cancer |
Comparison of anal cancer screening strategies including standard anoscopy, anal cytology, and HPV genotyping in HIV-positive men who have sex with men |
aoû. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancer |
déc. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Potentiating the effects of radiotherapy in rectal cancer: the role of aspirin, statins and metformin as adjuncts to therapy |
juil. 17 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer |
déc. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Tumour sidedness and intrinsic subtypes in patients with stage II/III colon cancer: analysis of NSABP C-07 (NRG Oncology). |
mar. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients |
aoû. 17 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma |
Jan. 19 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry |
sep. 17 |
2 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
A phase 2 randomised study of veliparib plus FOLFIRI ± bevacizumab versus placebo plus FOLFIRI ± bevacizumab in metastatic colorectal cancer |
Jan. 19 |
1 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer |
nov. 15 |
1 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
The presence of lymphovascular and perineural infiltration after neoadjuvant therapy and oesophagectomy identifies patients at high risk for recurrence |
nov. 15 |
1 ♥ |
Cancers autres |
British journal of Cancer |
Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study. |
juin. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer |
Jan. 17 |
2 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Tumour-stroma ratio and prognosis in gastric adenocarcinoma |
aoû. 18 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours |
mar. 19 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis |
mai. 17 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Long-term outcomes of patients with 10 or more colorectal liver metastases |
aoû. 17 |
2 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
The value of using the faecal immunochemical test in general practice on patients presenting with non-alarm symptoms of colorectal cancer |
aoû. 18 |
1 ♥ |
Cancer colorectal (CCR) |
Annals of oncology |
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX |
juin. 16 |
2 ♥ |
Cancer colorectal (CCR) |
Annals of oncology |
Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study. |
sep. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |